Strand Life Sciences Private Limited

Strand Life Sciences Private Limited - life sciences in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U85199KA2000PTC027913 Incorporated 06 October 2000 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company life sciences MSME
Data last updated
Revenue · FY 2026
₹123.94 Cr
▲ 3% YoY
Net loss · FY 2026
₹27.76 Cr
Net margin -22.4%
EBITDA · FY 2026
-₹26.56 Cr
EBITDA margin -21.4%
Authorised capital
₹28.1 Cr
Registered with MCA
Paid-up capital
₹24.39 Cr
Issued & subscribed
Open charges
₹1.5 Cr
Satisfied ₹35.02 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
428
Provident fund records

About Strand Life Sciences Private Limited

Data last updated:

Strand Life Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Reliance Digital Health Limited. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 06 October 2000 and has been in existence for over 26 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85199KA2000PTC027913. Its GSTIN is 29AAECS9651G1ZX (Karnataka). The company holds 9 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹28.1 Cr and a paid-up capital of ₹24.39 Cr. It was formerly known as Strand Genomics Private Limited. It is led by directors including Ramesh Hariharan (Whole-Time Director) and Nikhil K S Chakrapani.

Its last annual general meeting (AGM) was held on 03 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Bangalore, Karnataka.

As per the financials filed for FY 2026, the company reported a revenue of ₹123.94 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹27.76 Cr (net margin -22.4%) and EBITDA of -₹26.56 Cr (EBITDA margin -21.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 7% over five years.

The company has about 428 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Strand NGS and Strand Life Sciences. As per MCA filings, the company has open charges of ₹1.5 Cr and satisfied charges of ₹35.02 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 27 deals on record (19 secondary share transfers, 4 funding rounds, 2 convertible or debt financings), with disclosed funding of ₹249.96 Cr; the latest was in September 2025.

Strand Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-KR-03-0000644). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website strandls.com.

Company details

CIN U85199KA2000PTC027913
Registration Number 027913
Incorporation Date 06 October 2000
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 03 September 2026
Date of Balance Sheet 31 March 2026
Parent Company Reliance Digital Health Limited
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-KR-03-0000644

Recognitions & Rankings of Strand Life Sciences

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-KR-03-0000644

Contact details

Strand Life Sciences Private Limited's registered office is in Bangalore, Karnataka. Its website is strandls.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    7th Floor M S R North Tower 144 Dr Puneeth, Rajkumar Road Outer Ring Road Nagawara, Bangalore, Karnataka, India – 560045
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Strand Life Sciences Private Limited, buy the company report.

Comprehensive company report
Strand Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Strand Life Sciences operates two associated brands: Strand NGS and Strand Life Sciences. Each brand links to its own profile.

BrandDescriptionWebsite
Integrated platform for NGS data analysis, management, visualization, and workflows.strand-ngs.com
Provider of omics-based solutions for clinical genomics, systems biology, and drug discoverystrandls.com

Business activity

The main business activity of Strand Life Sciences is professional, scientific and technical activities. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, scientific and technical activities72Scientific research and development

To see the full business activity and turnover split of Strand Life Sciences Private Limited, buy the company report.

Financials of Strand Life Sciences Private Limited

FY 2026 filings available

Strand Life Sciences Private Limited reported revenue of ₹123.94 Cr (up 3% YoY) for FY 2026.

Revenue · FY 2026
₹123.94 Cr ▲ 3%
Net loss · FY 2026
₹27.76 Cr margin -22.4%
EBITDA · FY 2026
-₹26.56 Cr margin -21.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 12%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 380%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 3% growth in the latest year. EBITDA fell 380% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹123.94 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹26.56 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹27.76 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-21.4%
Net Profit Margin-22.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Strand Life Sciences Private Limited, buy the company report.

Board of directors of Strand Life Sciences Private Limited

Strand Life Sciences has 6 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nikhil K S ChakrapaniDirector07 Jan 20224 Years 10 MonthsCurrent
Nilesh Pramodkumar ModiDirector07 Jan 20224 Years 10 MonthsCurrent
Rahul Yogendra DuttDirector19 Jan 20224 Years 9 MonthsCurrent
Vijaya ChandruDirector23 Oct 200026 Years 0 MonthsCurrent
Ramesh HariharanWhole-Time Director01 Oct 201115 Years 1 MonthsCurrent
Achuthan SiddharthDirector19 Feb 20224 Years 8 MonthsCurrent

Auditor

Strand Life Sciences Private Limited is audited by CHATURVEDI & SHAH LLP for the financial year 2026.

Auditor firmFinancial yearFirm registration number
CHATURVEDI & SHAH LLPFY 2026101720W / W100355

Shareholding

The shareholding of Strand Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Strand Life Sciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.5 Cr
Satisfied charges
₹35.02 Cr
Breakdown by lending institutions
Others₹1.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Jul 2025101135968Others₹1.5 CrOpen
21 Dec 2018100240755Yes Bank Limited₹18 CrSatisfied
18 Apr 2017100094345Others₹2.25 CrSatisfied
06 Aug 201410515635Kotak Mahindra Bank Limited₹5 CrSatisfied
27 May 201110432873Department of Biotechnology (Ministry of Science and Technology)₹2.17 CrSatisfied

To see the full charge records of Strand Life Sciences Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Strand Life Sciences Private Limited has 27 deals on record (19 secondary share transfers, 4 funding rounds, 2 convertible or debt financings), with disclosed funding of ₹249.96 Cr; the latest was in September 2025.

Total deals
27
Secondary share transfers
19
Funding rounds
4
Convertible or debt financings
2
Acquisitions
2
Disclosed funding
₹249.96 Cr

Deals on record (5 of 27)

WhenDealAmountParties
May 2023Secondary share transferUndisclosedBuyer: Reliance Digital Health Limited
Seller: Glentech International, 3 individuals
Jun 2022Secondary share transferUndisclosedBuyer: Reliance Digital Health Limited
Seller: Reliance Strategic Business Ventures Limited , Biomark Capital, Berkley Investment Ltd
Sep 2021Acquisition₹340.43 CrBuyer: Reliance Strategic Business Ventures Limited
Seller: Healthcare Global Enterprises Limited , Quadria Capital, HealthQuad
Sep 2021Acquisition₹80.8 CrBuyer: Healthcare Global Enterprises Limited
Seller: Strand Life Sciences Private Limited
Mar 2019Secondary share transferUndisclosedBuyer: Healthcare Global Enterprises Limited , 3 individuals
Seller: Strand Employees Welfare Trust, Connect Capital Pte Ltd, HealthQuad

To see the full deal history of Strand Life Sciences Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Strand Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Strand Life Sciences Private Limited has a workforce of 428 employees on its EPFO records as of Sep 24, 2025, across 1 active EPFO establishment.

Employee count
428
Active EPFO establishments
1
Employee growth
38.96%

GST

Strand Life Sciences has 9 GST registrations: 1 active and 8 cancelled or inactive.

Total GSTINs
9
Active
1
Cancelled / inactive
8
GSTINStateStatusRegistered on
29AAECS9651G1ZXKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Strand Life Sciences Private Limited, buy the company report.

Recent activity

Strand Life Sciences Private Limited has 40 board changes on record since 2000: 23 appointments and 17 cessations. The latest: Achuthan Siddharth was appointed as Director on 19 Feb 2022.

AGM
Strand Life Sciences Private Limited last Annual general meeting of members was held on 03 Sep 2026 as per latest MCA records.
Charges
A charge with Others of Rs. 1.50 Cr registered on 31 Jul 2025 with Charge ID 101135968 was modified on 29 Jun 2026.
Filing
Strand Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Bangalore.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101135968 was registered on 31 Jul 2025.
Charges
A charge registered on 21 Dec 2018 via Charge ID 100240755 with Yes Bank Limited was fully satisfied on 07 Apr 2022.
Appointed
Achuthan Siddharth was appointed as Director.
Appointed
Rahul Yogendra Dutt was appointed as Director.
Appointed
Nikhil K S Chakrapani was appointed as Director.
Appointed
Nilesh Pramodkumar Modi was appointed as Director.
Ceased
Amit Soni ceased to be Nominee Director.
Ceased
Amit Varma ceased to be Nominee Director.
Ceased
Basavalinga Ajaikumar Sadasivaiah ceased to be Nominee Director.

46 earlier events are in the company report.

Frequently asked questions

Strand Life Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 06 October 2000 (26+ years old) and is registered under CIN U85199KA2000PTC027913.

Strand Life Sciences has 6 current directors:

The latest financial statements of Strand Life Sciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 03 September 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Strand Life Sciences is 29AAECS9651G1ZX, registered in Karnataka. The company has 9 GST registrations in all, of which 1 is active and 8 are cancelled or inactive.

The CIN (Corporate Identification Number) of Strand Life Sciences is U85199KA2000PTC027913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Strand Life Sciences has 2 court cases on record: 2 filed against it.

Strand Life Sciences was incorporated on 06 October 2000, making it 26+ years old. It is registered with the Registrar of Companies, Bangalore.

Strand Life Sciences has 27 deals on record (19 secondary share transfers, 4 funding rounds, 2 convertible or debt financings), with disclosed funding of ₹249.96 Cr; the latest was in September 2025.

Achuthan Siddharth was appointed as Director on 19 Feb 2022. Rahul Yogendra Dutt was appointed as Director on 19 Jan 2022. Nikhil K S Chakrapani was appointed as Director on 07 Jan 2022. Strand Life Sciences has 40 board changes on record in total.

Yes, Strand Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-KR-03-0000644).